Evidence map›Paper›PMID 37555379›Full record

ArticleBiotechnology and bioengineering2023

High performance anion exchange chromatography purification of probiotic bacterial extracellular vesicles enhances purity and anti-inflammatory efficacy.

Nicholas H Pirolli, Laura Samantha C Reus, Zuzanna Mamczarz, Sulayman Khan, William E Bentley, Steven M Jay

Open access · hybridAbstract read
In one paragraph

Article in Biotechnology and bioengineering, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Extracellular Vesicle Preparation and Analysis: A State-of-the-Art Review.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nicholas H PirolliFischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
Laura Samantha C ReusFischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
Zuzanna MamczarzFischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
Sulayman KhanFischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
William E BentleyFischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.ORCID 0000-0002-4855-7866
Steven M JayFischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.ORCID 0000-0002-3827-5988
University of Maryland, College Park · USInstitute for Bioscience and Biotechnology Research

Funding

University of Maryland Center of Excellence in Regulatory Science and InnovationU01FD005946 · FDA · UNIV OF MARYLAND, COLLEGE PARK · PI BENTLEY, WILLIAM E., POLLI, JAMES E · 2016 to 2025
$21.5M
Nanohydrocyclones for scalable extracellular vesicle purification and drug loadingR21HL159590 · NHLBI · UNIV OF MARYLAND, COLLEGE PARK · PI DEVOE, DON L, JAY, STEVEN MICHAEL · 2021 to 2022
$421k
FDA HHS U01 FD005946FDA HHS U01FD005946NHLBI NIH HHS R21 HL159590NIH HHS HL159590
6 · The paper itself

Abstract

Bacterial extracellular vesicles (BEVs), including outer membrane vesicles, have emerged as a promising new class of vaccines and therapeutics to treat cancer and inflammatory diseases, among other applications. However, clinical translation of BEVs is hindered by a current lack of scalable and efficient purification methods. Here, we address downstream BEV biomanufacturing limitations by developing a method for orthogonal size- and charge-based BEV enrichment using tangential flow filtration (TFF) in tandem with high performance anion exchange chromatography (HPAEC). The data show that size-based separation coisolated protein contaminants, whereas size-based TFF with charged-based HPAEC dramatically improved purity of BEVs produced by probiotic Gram-negative Escherichia coli and Gram-positive lactic acid bacteria (LAB). Escherichia coli BEV purity was quantified using established biochemical markers while improved LAB BEV purity was assessed via observed potentiation of anti-inflammatory bioactivity. Overall, this work establishes orthogonal TFF + HPAEC as a scalable and efficient method for BEV purification that holds promise for future large-scale biomanufacturing of therapeutic BEV products.

Indexed as

Anti-Inflammatory AgentsEscherichia coliExtracellular VesiclesProbioticsAnimalsChromatography, Ion ExchangeMiceAnti-Inflammatory Agentsbacterial therapeuticsouter membrane vesiclesprobioticspurification

Identifiers

PMID37555379
PMCPMC10592193
OpenAlexW4385683753

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.